期刊文献+

血栓抽吸后行直接冠状动脉支架置入术对急性ST段抬高心肌梗死患者的疗效观察 被引量:4

Effectiveness in thrombus aspiration followed by direct coronary stent implantation in patient with ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的评估血栓抽吸(TA)后行直接冠状动脉支架置入术对ST段抬高心肌梗死(STEMI)患者预后的影响。方法纳入2011年12月至2014年7月因STEMI入院且发病在12 h内并行直接冠状动脉支架置入术、符合入选标准的患者443例,其中TA后直接置入支架患者113例(TA组),TA后球囊预扩张(BP)患者330例(TA+BP组)。主要终点:12个月主要不良心血管事件(MACE)的发生情况;次要终点:靶血管远段栓塞和支架内血栓形成。结果所有患者均成功置入支架。TA组患者术后60 min内ST段回落>50%的比例(69.0%比51.8%,P=0.001)显著大于TA+BP组,差异有统计学意义。TA组TIMI血流≥Ⅱ级在TA后即刻(76.1%比65.8%,P=0.043)、支架置入前/BP后(76.1%比62.4%,P=0.012)、支架置入后(92.0%比84.5%,P=0.042)及手术结束前(95.6%比91.2%,P=0.033)比例显著大于TA+BP组,差异均有统计学意义;而术中因TIMI血流欠佳或血栓负荷仍较重而补救性使用血小板糖蛋白Ⅱb/Ⅲa抑制药的比例(16.8%比27.6%,P=0.026)及靶血管远段栓塞的比例(6.2%比13.3%,P=0.040)显著低于TA+BP组,差异亦均有统计学意义。虽然两组患者在住院期间和随访12个月的MACE发生率比较差异无统计学意义,但TA组患者总MACE发生率(5.3%比11.8%,P=0.041)显著低于TA+BP组,差异有统计学意义。结论TA后行直接冠状动脉支架置入术可改善STEMI患者最终的心肌再灌注,从而改善患者短期临床预后。 Objective Compared with routine balloon predilatation( BP) in ST-elevation myocardial infarction( STEMI) patients,the aim of the present study was to assess impact of selective thrombus aspiration( TA) followed by direct coronary stent implantation. Methods Between Dec 2011 and Jul 2014,a total of 443 patients( 113 patients in TA group and 330 patients in TA + BP group) who were eligible for the observation criteria,admitted with STEMI( within 12 h from symptoms onset) and candidates for direct coronary stent implantation were enrolled. The major indexes of this study were the 12 month major adverse cardiac events( MACE). Secondary indexes included distal embolizations of infarct-related artery and stent thrombosis. Results Procedural success was obtained in all patients. The rate of 60 min STsegment resolution 50% was significantly higher in the TA group than in the TA + BP group( 69. 0% vs.51. 8%,P = 0. 001). The rates of TIMI grade Ⅱ or Ⅲ flow following stent implantation and befor the end of the operation were significantly higher among patients in TA group compared with TA + BP group,respectively( 92. 0% vs. 84. 5%,95. 6% vs. 91. 2%,all P 0. 05). The rate of evident distal embolizations in patietnts of TA group was significantly lower than that in TA + BP group( 6. 2% vs.13. 3%,P = 0. 040). There was no difference among the groups in in-hospital or 12-month MACE,respectively( 1. 8% vs. 2. 1%,3. 5% vs. 9. 1%,all P 0. 05). But total MACE was significantly disease in the TA group compared with the TA + BP group( 5. 3% vs. 11. 8%, P = 0. 041).Conclusions Compared with conventional primary PCI,selective TA and direct stenting procedure may improve final myocardial reperfusion and the one-year outcomes for STEMI patients.
出处 《中国介入心脏病学杂志》 2016年第11期646-650,共5页 Chinese Journal of Interventional Cardiology
基金 辽宁省自然科学基金(2014020064) 2014中国心血管疾病药物治疗研究基金项目(LSG2014-2047)
关键词 心肌梗死 冠状动脉支架置入术 血栓抽吸 Myocardial infarction Coronary stent implatation Thrombus aspiration
  • 相关文献

参考文献4

二级参考文献31

  • 1Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 2Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
  • 3Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
  • 4Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
  • 5Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
  • 6Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
  • 7Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
  • 8Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
  • 9Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.
  • 10Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Cell Cardiol,2007,50 : 1742-1751.

共引文献2395

同被引文献22

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部